PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
33110441-11	2020	The putative targets of YZG that treat ODUB mainly involved PTGS1, PTGS2, ALOX5, CASP3, LTA4H, F7 and F10.	yzg	24-27	prostaglandin-endoperoxide synthase 1	Homo sapiens	60-65
33110441-11	2020	The putative targets of YZG that treat ODUB mainly involved PTGS1, PTGS2, ALOX5, CASP3, LTA4H, F7 and F10.	yzg	24-27	prostaglandin-endoperoxide synthase 2	Homo sapiens	67-72
33110441-11	2020	The putative targets of YZG that treat ODUB mainly involved PTGS1, PTGS2, ALOX5, CASP3, LTA4H, F7 and F10.	yzg	24-27	arachidonate 5-lipoxygenase	Homo sapiens	74-79
33110441-11	2020	The putative targets of YZG that treat ODUB mainly involved PTGS1, PTGS2, ALOX5, CASP3, LTA4H, F7 and F10.	yzg	24-27	caspase 3	Homo sapiens	81-86
33110441-11	2020	The putative targets of YZG that treat ODUB mainly involved PTGS1, PTGS2, ALOX5, CASP3, LTA4H, F7 and F10.	yzg	24-27	leukotriene A4 hydrolase	Homo sapiens	88-93
28848441-9	2017	Flavin-containing monooxygenase 1 (FMO1) and FMO3 participated in the conversion of YZG-331 in rat LMs.	yzg	84-87	flavin containing dimethylaniline monoxygenase 1	Rattus norvegicus	0-33
28848441-9	2017	Flavin-containing monooxygenase 1 (FMO1) and FMO3 participated in the conversion of YZG-331 in rat LMs.	yzg	84-87	flavin containing dimethylaniline monoxygenase 1	Rattus norvegicus	35-39
28848441-9	2017	Flavin-containing monooxygenase 1 (FMO1) and FMO3 participated in the conversion of YZG-331 in rat LMs.	yzg	84-87	flavin containing dimethylaniline monoxygenase 3	Rattus norvegicus	45-49
27612629-3	2016	The activity of P-gp ATPase was both induced by YZG-331 and verapamil, a typical P-gp inhibitor, but affinity of YZG-331 for P-gp was lower than that of verapamil.	yzg	48-51	PGP	Canis lupus familiaris	16-20
27612629-3	2016	The activity of P-gp ATPase was both induced by YZG-331 and verapamil, a typical P-gp inhibitor, but affinity of YZG-331 for P-gp was lower than that of verapamil.	yzg	48-51	PGP	Canis lupus familiaris	81-85
27612629-3	2016	The activity of P-gp ATPase was both induced by YZG-331 and verapamil, a typical P-gp inhibitor, but affinity of YZG-331 for P-gp was lower than that of verapamil.	yzg	48-51	PGP	Canis lupus familiaris	81-85
27612629-4	2016	The docking analyses further elucidated the binding relationship of YZG-331 and P-gp.	yzg	68-71	PGP	Canis lupus familiaris	80-84
27612629-5	2016	The directional transport of YZG-331 was disappeared in Caco-2 and MDCK-MDR1 cells when the P-gp activity was blocked.	yzg	29-32	PGP	Canis lupus familiaris	92-96
27612629-11	2016	The intestine and brain permeability of YZG-331 can be restricted, at least in part, by P-gp.	yzg	40-43	PGP	Canis lupus familiaris	88-92
17058837-2	2006	METHODS: Intracellular cytokines secreted by Th1/Th2 were measured using flow cytometry in 24 healthy subjects and 31 IgAN patients treated by YZG before and after treatment.	yzg	143-146	negative elongation factor complex member C/D	Homo sapiens	45-48
17058837-4	2006	After YZG treatment, the level of IFN-gamma increased and IL-10 level decreased (P < 0.01).	yzg	6-9	interferon gamma	Homo sapiens	34-43
17058837-4	2006	After YZG treatment, the level of IFN-gamma increased and IL-10 level decreased (P < 0.01).	yzg	6-9	interleukin 10	Homo sapiens	58-63